Wikidata entity: Q417640
C₉H₁₃N₅O₄ (P274)
Quantities
| P2067 | mass | 255.097 |
| P3780 | active ingredient in | ... | Q29006661 (Vitrasert Implant) | Vitrasert Implant |
| P3780 | active ingredient in | ... | Q47521433 (Cytovene) | Cytovene |
| P3780 | active ingredient in | ... | Q47522350 (Zirgan) | Zirgan |
| P233 | canonical SMILES | String | C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N | ??? |
| P972 | catalog | ... | Q90481889 (CAS COVID-19 Anti-Viral Candidate Compounds) | CAS COVID-19 Anti-Viral Candidate Compounds |
| P373 | Commons category | String | Ganciclovir | ??? |
| P703 | found in taxon | ... | Q10400000 (Acremonium persicinum) | Acremonium persicinum |
| P703 | found in taxon | ... | Q15978631 (Homo sapiens) | Homo sapiens |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Ganciclovir%20ball-and-stick.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P2175 | medical condition treated | ... | Q835718 (opportunistic infection) | opportunistic infection |
| P2175 | medical condition treated | ... | Q1258984 (herpes simplex virus keratitis) | herpes simplex virus keratitis |
| P2175 | medical condition treated | ... | Q2076966 (cytomegaloviral disease) | cytomegaloviral disease |
| P2175 | medical condition treated | ... | Q4271835 (cytomegalovirus retinitis) | cytomegalovirus retinitis |
| P2175 | medical condition treated | ... | Q18553800 (neuroretinitis) | neuroretinitis |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q180609 (intravitreal administration) | intravitreal administration |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q422606 (didanosine) | didanosine |
| P279 | subclass of | ... | Q2118866 (purine alkaloid) | purine alkaloid |
| P279 | subclass of | ... | Q2689559 (nucleoside analogue) | nucleoside analogue |
| P2868 | subject has role | ... | Q187661 (carcinogen) | carcinogen |
| P2868 | subject has role | ... | Q804539 (bactericide) | bactericide |
| P2868 | subject has role | ... | Q846227 (antiviral drug) | antiviral drug |
| P2868 | subject has role | ... | Q4118287 (DNA polymerase inhibitors) | DNA polymerase inhibitors |
| P2868 | subject has role | ... | Q40207875 (antiviral agent) | antiviral agent |
| P2868 | subject has role | ... | Q55427774 (male reproductive toxicant) | male reproductive toxicant |
| P2868 | subject has role | ... | Q72941151 (developmental toxicant) | developmental toxicant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | ganciclovir | ??? |
Why not click here or view trends?
log id: 1950798